Newest
-
The Backbone of the Tianshan Mountains Paves the Way! Kurla to Buluntai Section of Xinjiang's Urumqi-Yuli Expressway Opens to Traffic
-
MCN GLOBAL Officially Files Under SEC Regulation D, Ushering in a New Era of Global Compliance
-
Global Museum Experts Gather at 2025 Museum Summit to Chart Future of Cultural Institutions
-
La inauguración del Foro Internacional de Servicios Legales de la "Franja y la Ruta" Un impulsor activo de la cooperación internacional en la aplicación de la ley y la justicia por parte de China
Intelligent
-
Ascenda and Galileo Financial Technologies Collaborate to Elevate Card Loyalty Programs
Partnership combines Galileo\'s technology platform andAscenda\'s loyalty expertise to simplify and power card loyalty programs
02-26
Details -
Cedro Participações signs concession contract for the Port of Itaguaí at an event with President Lula and Minister Silvio Costa Filho
The company will be the first 100% Brazilian mining company to verticalize its operations and intends to invest R$3.6 billion in the project
02-26
Details -
The 2025 Wynn Signature Chinese Wine Awards Judging Week Commences at the End of February
The 6-day event features higher competition standards with an elevated panel of 27 acclaimed judges,plus a series of events including wine seminars,Masterclasses,and wine dinners
02-26
Details -
GILF Shortlisted in Catalog of Guangdong's Nationwide Trade Initiative (2025), Starting New Procurement Season in March
ZHONGSHAN,China,Feb. 25,2025-- Recently,the official website of the Department of Commerce of Guangdong Province released the Catalog of Guangdong\'s Nationwide Trade Initiative (2025). After submissi
02-26
Details -
Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs
HONG KONG,Feb. 25,2025--Akeso,Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab,Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a c
02-26
Details -
YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)
SHANGHAI,Feb. 25,2025-- YolTech Therapeutics,a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines,today reported positive results fr
02-26
Details -
Yatsen Announces Fourth Quarter and Full Year 2024 Financial Results
Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on February 25,2025 GUANGZHOU,China,Feb. 25,2025--Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG),a leading
02-26
Details -
Foxit Supercharges AI Assistant with Multi-Document Analysis on iOS & Android
Enables Users to Boost Productivity with AI-Powered Summaries,Cross-Document Insights,and Instant Data Extraction Across Mobile Device
02-26
Details -
Vialto Partners Completes Recapitalization Transaction
Transaction Completely and Definitively Transforms Vialto\'s Capital Structure,Delivering a $225 Million New Money Equity Capital Investment in Vialto and a Reduction of Approximately $550 Million of
02-26
Details -
Axiad Applauded by Frost & Sullivan for Providing Phishing-resistant Authentication with PKI-based Authentication
Axiad\'s PKI-based authentication enables scalability and flexibility in large-scale enterprise environments,elevates user experience and streamlines user access control
02-26
Details